Cargando…
Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes
This cross-sectional study investigated the association of metabolic syndrome (MetS) with sarcopenia defined by absolute low muscle mass (aLMM) and absolute low muscle strength (aLMS), or sarcopenia defined by relative low muscle mass (rLMM) and relative low muscle strength (rLMS). The cut-off value...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519414/ https://www.ncbi.nlm.nih.gov/pubmed/36213794 http://dx.doi.org/10.3164/jcbn.21-152 |
_version_ | 1784799392924958720 |
---|---|
author | Takegami, Maya Hashimoto, Yoshitaka Hamaguchi, Masahide Kaji, Ayumi Sakai, Ryosuke Okamura, Takuro Kitagawa, Noriyuki Osaka, Takafumi Okada, Hiroshi Nakanishi, Naoko Majima, Saori Senmaru, Takafumi Ushigome, Emi Asano, Mai Yamazaki, Masahiro Fukui, Michiaki |
author_facet | Takegami, Maya Hashimoto, Yoshitaka Hamaguchi, Masahide Kaji, Ayumi Sakai, Ryosuke Okamura, Takuro Kitagawa, Noriyuki Osaka, Takafumi Okada, Hiroshi Nakanishi, Naoko Majima, Saori Senmaru, Takafumi Ushigome, Emi Asano, Mai Yamazaki, Masahiro Fukui, Michiaki |
author_sort | Takegami, Maya |
collection | PubMed |
description | This cross-sectional study investigated the association of metabolic syndrome (MetS) with sarcopenia defined by absolute low muscle mass (aLMM) and absolute low muscle strength (aLMS), or sarcopenia defined by relative low muscle mass (rLMM) and relative low muscle strength (rLMS). The cut-off values for men and women were as follows: aLMM, appendicular muscle mass in kg/height(2) was <7.0 kg/m(2) and <5.7 kg/m(2); rLMM, appendicular muscle mass/body weight ×100 was <28.64% and <24.12%; aLMS, handgrip strength was <28 kg and <18 kg; and rLMS, handgrip strength/body weight ×100 was 51.26% and 35.38%. Among 207 men and 164 women, 41.5% men and 57.3% women had MetS, 14.0% men and 6.1% women had sarcopenia as defined by aLMM and aLMS, and 14.0% men and 22.0% women had sarcopenia defined by rLMM and rLMS. Compared with non-sarcopenia, adjusted OR of sarcopenia defined by aLMM and aLMS for the prevalence of MetS was 0.79 (95% CI 0.38–1.67), whereas that of sarcopenia defined by rLMM and rLMS for the prevalence of MetS was 20.6 (95% CI 7.81–54.3). Sarcopenia defined by rLMM and rLMS was associated with the risk of prevalence of MetS, whereas sarcopenia defined by aLMM and aLMS was not. |
format | Online Article Text |
id | pubmed-9519414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | the Society for Free Radical Research Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-95194142022-10-06 Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes Takegami, Maya Hashimoto, Yoshitaka Hamaguchi, Masahide Kaji, Ayumi Sakai, Ryosuke Okamura, Takuro Kitagawa, Noriyuki Osaka, Takafumi Okada, Hiroshi Nakanishi, Naoko Majima, Saori Senmaru, Takafumi Ushigome, Emi Asano, Mai Yamazaki, Masahiro Fukui, Michiaki J Clin Biochem Nutr Original Article This cross-sectional study investigated the association of metabolic syndrome (MetS) with sarcopenia defined by absolute low muscle mass (aLMM) and absolute low muscle strength (aLMS), or sarcopenia defined by relative low muscle mass (rLMM) and relative low muscle strength (rLMS). The cut-off values for men and women were as follows: aLMM, appendicular muscle mass in kg/height(2) was <7.0 kg/m(2) and <5.7 kg/m(2); rLMM, appendicular muscle mass/body weight ×100 was <28.64% and <24.12%; aLMS, handgrip strength was <28 kg and <18 kg; and rLMS, handgrip strength/body weight ×100 was 51.26% and 35.38%. Among 207 men and 164 women, 41.5% men and 57.3% women had MetS, 14.0% men and 6.1% women had sarcopenia as defined by aLMM and aLMS, and 14.0% men and 22.0% women had sarcopenia defined by rLMM and rLMS. Compared with non-sarcopenia, adjusted OR of sarcopenia defined by aLMM and aLMS for the prevalence of MetS was 0.79 (95% CI 0.38–1.67), whereas that of sarcopenia defined by rLMM and rLMS for the prevalence of MetS was 20.6 (95% CI 7.81–54.3). Sarcopenia defined by rLMM and rLMS was associated with the risk of prevalence of MetS, whereas sarcopenia defined by aLMM and aLMS was not. the Society for Free Radical Research Japan 2022-09 2022-03-08 /pmc/articles/PMC9519414/ /pubmed/36213794 http://dx.doi.org/10.3164/jcbn.21-152 Text en Copyright © 2022 JCBN https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Original Article Takegami, Maya Hashimoto, Yoshitaka Hamaguchi, Masahide Kaji, Ayumi Sakai, Ryosuke Okamura, Takuro Kitagawa, Noriyuki Osaka, Takafumi Okada, Hiroshi Nakanishi, Naoko Majima, Saori Senmaru, Takafumi Ushigome, Emi Asano, Mai Yamazaki, Masahiro Fukui, Michiaki Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes |
title | Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes |
title_full | Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes |
title_fullStr | Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes |
title_full_unstemmed | Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes |
title_short | Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes |
title_sort | relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519414/ https://www.ncbi.nlm.nih.gov/pubmed/36213794 http://dx.doi.org/10.3164/jcbn.21-152 |
work_keys_str_mv | AT takegamimaya relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT hashimotoyoshitaka relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT hamaguchimasahide relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT kajiayumi relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT sakairyosuke relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT okamuratakuro relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT kitagawanoriyuki relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT osakatakafumi relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT okadahiroshi relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT nakanishinaoko relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT majimasaori relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT senmarutakafumi relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT ushigomeemi relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT asanomai relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT yamazakimasahiro relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes AT fukuimichiaki relativelowmusclemassandmusclestrengthisassociatedwiththeprevalenceofmetabolicsyndromeinpatientswithtype2diabetes |